Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
09/2005
09/15/2005WO2005054430A3 Hepatitis c virus inhibitors
09/15/2005WO2005051937A3 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof
09/15/2005WO2005049604A3 Antithrombotic aromatic ethers
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005US20050203167 Diphenylmethyl compounds useful as muscarinic receptor antagonists
09/15/2005US20050203158 Substituted benzimidazole compounds
09/15/2005US20050203155 Imidazole compounds and human cellular proteins casein kinase I alpha, delta and epsilon as targets for medical intervention against Hepatitis C Virus infections
09/15/2005US20050203146 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
09/15/2005US20050203145 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries
09/15/2005US20050203138 Biphenyl compounds useful as muscarinic receptor antagonists
09/15/2005US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection
09/15/2005US20050203134 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-[4-(4-carbamoylpiperidin-1-ylmethyl)phenylcarbamoyl]ethyl)piperidin-4-yl ester
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203104 Cycloalkyl - containing 5-acylindolinones, the preparation thereof and their use as medicaments
09/15/2005US20050203101 Benzimidazole quinolinones and uses thereof
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050203092 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods
09/15/2005CA2558278A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005CA2557322A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005CA2556387A1 Bicyclic anthranilamide derivatives useful as insecticides
09/15/2005CA2555712A1 Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein
09/15/2005CA2553252A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides
09/14/2005EP1574511A1 2-Pyridinylethylcarboxamide derivatives and their use as fungicides
09/14/2005EP1574510A1 Substituted pyridine herbicides
09/14/2005EP1573391A2 Second order nonlinear optical chromophores, polymers containing same, and electro-optic devices therefrom
09/14/2005EP1572686A1 Anthranilic acid amide derivatives and their pharmaceutical use
09/14/2005EP1572681A1 3-substituted-4-pyrimidone derivatives
09/14/2005EP1572676A2 High specificity anticancer pharmacological drug system, drug synthesis, and drug development process
09/14/2005EP1572670A1 5-substituted-pyrazine or -pyridine glucokinase activators
09/14/2005EP1572667A1 Cathepsin cysteine protease inhibitors and their use
09/14/2005EP1572664A1 Pyrazole compounds
09/14/2005EP1572662A1 Pyrazole and imidazole compounds and uses thereof
09/14/2005EP1572660A1 Isoquinolinone derivatives and their use as therapeutic agents
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572648A1 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists
09/14/2005EP1572647A2 Synthesis of amines and intermediates for the synthesis thereof
09/14/2005EP1572641A1 Method for production of the r,r (or s,s) configuration of glycopyrronium stereoisomers
09/14/2005EP1572638A2 An improved process for the preparation of amorphous atorvastatin calcium salt (2:1)
09/14/2005EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
09/14/2005EP1572215A1 Benzo[d]azepine derivatives for the treatment of neurological disorders
09/14/2005EP1572209A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists
09/14/2005EP1572199A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
09/14/2005EP1572112A2 3-(pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openers
09/14/2005EP1572072A2 Methods of treating infection by drug resistant bacteria
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005EP1289954B1 Serine protease inhibitors
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005CN1668703A Charge transport compositions on the basis of triarylmethanes and their use in electronic devices
09/14/2005CN1668616A Charge transport compositions comprising fluorizated quinazoline derivatives
09/14/2005CN1668603A Pyridazin-3(2h)-one derivatives as PDE4 inhibitors
09/14/2005CN1668600A 5-substituted isoquinoline derivatives
09/14/2005CN1668590A 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
09/14/2005CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
09/14/2005CN1668300A Spirocyclic piperidines as MCH1 antagonists and uses thereof
09/14/2005CN1666983A Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest contollers and a method for using the same
09/13/2005US6943252 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
09/13/2005US6943189 mixture of sulfur compounds and 3-hydroxy-3-methylglutaryl-coenzyme A inhibitors, used for prophylaxis of hyperlipemia in mammals
09/13/2005US6943183 Antiproliferative agnets; anticancer agents; skin disorders; restenosis
09/13/2005US6943182 Cyclopentabenzofuran derivatives and their use
09/13/2005CA2371583C Piperazine derivatives useful as ccr5 antagonists
09/13/2005CA2317462C 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
09/13/2005CA2279276C Arylsulfonylamino hydroxamic acid derivatives
09/13/2005CA2216099C Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
09/13/2005CA2179634C 4-arylisoindole analgesics
09/09/2005WO2005082890A1 Novel compounds
09/09/2005WO2005082874A1 Novel benzothiazepine and benzothiepine compounds
09/09/2005WO2005082863A2 1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors
09/09/2005WO2005082859A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
09/09/2005WO2005082858A2 Isoquinoline derivatives
09/09/2005WO2005082856A2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/09/2005WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1)
09/09/2005WO2005082367A1 Kinase inhibitors
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005WO2005044192A3 Triazole compounds and uses related thereto
09/09/2005WO2005032493A3 Amide compounds as ion channel ligands and uses thereof
09/09/2005WO2005009373A3 Tyrosine kinase inhibitors
09/09/2005CA2555720A1 Isoquinoline derivatives
09/09/2005CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1)
09/08/2005US20050198462 Charge transfer complexes including an electron donor and an electron acceptor as basis of resistive memories
09/08/2005US20050197375 Use of benzimidazole analogs in the treatment of cell proliferation
09/08/2005US20050197364 Amide compounds as ion channel ligands and uses thereof
09/08/2005US20050197361 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/08/2005US20050197350 Melanin Concentrating Hormone (MCH) receptor antagonist; clinical obesity; eating disorders; N-(cis-4-{[4-(dimethylamino)quinolin-2-yl]amino}cyclohexyl)-3-methoxy-benzamide; N-(2-chlorobenzyl)-N'-(cis-4-{[4- -(dimethylamino)-5,6,7,8-tetrahydroquinazolin-2-yl]amino}cyclohexyl)urea; pyrimidine analogs
09/08/2005US20050197345 Pyrrolidine sulfonamides
09/08/2005US20050197338 Substituted pyrazole urea compounds for the treatment of inflammation
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/08/2005US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species
09/08/2005US20050196813 Heterocyclic sulfonamide inhibitors of beta amyloid production
09/07/2005EP1571154A1 Beta-aminoacid-derivatives as factor Xa inhibitors
09/07/2005EP1571147A2 Pyrazole analogs acting on cannabinoid receptors
09/07/2005EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1569934A2 Cyclopropyl compounds as ccr5 antagonists
09/07/2005EP1569932A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1569929A1 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRUS /i INFECTIONS
09/07/2005EP1569926A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569925A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
1 ... 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 ... 523